| MicroRNA signatures in human ovarian cancer MV Iorio, R Visone, G Di Leva, V Donati, F Petrocca, P Casalini, C Taccioli, ... Cancer research 67 (18), 8699-8707, 2007 | 1926 | 2007 |
| microRNA-205 regulates HER3 in human breast cancer MV Iorio, P Casalini, C Piovan, G Di Leva, A Merlo, T Triulzi, S Ménard, ... Cancer research 69 (6), 2195-2200, 2009 | 443 | 2009 |
| Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity S Sangaletti, C Tripodo, C Chiodoni, C Guarnotta, B Cappetti, P Casalini, ... Blood, The Journal of the American Society of Hematology 120 (15), 3007-3018, 2012 | 441 | 2012 |
| FOXP3 expression and overall survival in breast cancer A Merlo, P Casalini, ML Carcangiu, C Malventano, T Triulzi, S Mènard, ... J Clin Oncol 27 (11), 1746-1752, 2009 | 352 | 2009 |
| Role of HER receptors family in development and differentiation P Casalini, MV Iorio, E Galmozzi, S Ménard Journal of cellular physiology 200 (3), 343-350, 2004 | 340 | 2004 |
| HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer S Menard, P Casalini, M Campiglio, S Pupa, R Agresti, E Tagliabue Annals of oncology 12, S15-S19, 2001 | 220 | 2001 |
| Oncogenic protein tyrosine kinases: Role of HER2/neu in tumor progression and therapy S Menard, P Casalini, M Campiglio, SM Pupa, E Tagliabue Cellular and Molecular Life Sciences CMLS 61, 2965-2978, 2004 | 215 | 2004 |
| Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node–positive breast cancer according to HER2 overexpression and other tumor biologic variables S Ménard, P Valagussa, S Pilotti, L Gianni, E Biganzoli, P Boracchi, ... Journal of Clinical Oncology 19 (2), 329-335, 2001 | 207 | 2001 |
| Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer C Piovan, D Palmieri, G Di Leva, L Braccioli, P Casalini, G Nuovo, ... Molecular oncology 6 (4), 458-472, 2012 | 196 | 2012 |
| Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis M Greco, R Agresti, N Cascinelli, P Casalini, R Giovanazzi, A Maucione, ... Annals of surgery 232 (1), 1-7, 2000 | 186 | 2000 |
| MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer MV Iorio, P Casalini, E Tagliabue, S Ménard, CM Croce European Journal of Cancer 44 (18), 2753-2759, 2008 | 182 | 2008 |
| Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity M Chinol, P Casalini, M Maggiolo, S Canevari, ES Omodeo, P Caliceti, ... British journal of cancer 78 (2), 189-197, 1998 | 163 | 1998 |
| Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas. S Menard, G Tomasic, P Casalini, A Balsari, S Pilotti, N Cascinelli, ... Clinical cancer research: an official journal of the American Association …, 1997 | 162 | 1997 |
| HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancer A Moliterni, S Ménard, P Valagussa, E Biganzoli, P Boracchi, A Balsari, ... Journal of Clinical Oncology 21 (3), 458-462, 2003 | 158 | 2003 |
| Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers M Di Modica, V Regondi, M Sandri, MV Iorio, A Zanetti, E Tagliabue, ... Cancer letters 384, 94-100, 2017 | 146 | 2017 |
| Selection of monoclonal antibodies which induce internalization and phosphorylation of p185HER2 and growth inhibition of cells with HER2/NEU gene amplification E Tagliabue, F Centis, M Campiglio, A Mastroianni, S Martignone, ... International journal of cancer 47 (6), 933-937, 1991 | 139 | 1991 |
| HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviors S Ménard, A Balsari, P Casalini, E Tagliabue, M Campiglio, R Bufalino, ... Clinical cancer research 8 (2), 520-525, 2002 | 133 | 2002 |
| Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphoma S Sangaletti, C Tripodo, C Vitali, P Portararo, C Guarnotta, P Casalini, ... Cancer discovery 4 (1), 110-129, 2014 | 128 | 2014 |
| Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells F Andriani, G Bertolini, F Facchinetti, E Baldoli, M Moro, P Casalini, ... Molecular oncology 10 (2), 253-271, 2016 | 126 | 2016 |
| Breast cancer and microRNAs: therapeutic impact MV Iorio, P Casalini, C Piovan, L Braccioli, E Tagliabue The Breast 20, S63-S70, 2011 | 126 | 2011 |
